The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

17 articles for W Hou


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Pharmacological activity and mechanism of pyrazines.EBI
Gannan Medical University
Diselenide Covalent Allosteric Inhibitors of Glutaminase with Strong EBI
Zhejiang University
Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology.EBI
Zhejiang University
Advances of CCR5 antagonists: From small molecules to macromolecules.EBI
Chengdu University
Synthesis of Novel Kidney-Type Glutaminase Allosteric Inhibitors Targeting the Critical Lys-320 Residue.EBI
Zhejiang University
Novel PHD2/HDACs hybrid inhibitors protect against cisplatin-induced acute kidney injury.EBI
Peking Union Medical College
Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors.EBI
Peking Union Medical College
Structure-based design, synthesis, and evaluation of inhibitors with high selectivity for PARP-1 over PARP-2.EBI
Shenyang Pharmaceutical University
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.EBI
Peking Union Medical College
Novel quinazoline derivatives bearing various 6-benzamide moieties as highly selective and potent EGFR inhibitors.EBI
Beijing Normal University
Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR Inhibitors.EBI
National Institute of Biological Sciences (Nibs)
Novel 1,3,4-Selenadiazole-Containing Kidney-Type Glutaminase Inhibitors Showed Improved Cellular Uptake and Antitumor Activity.EBI
Zhejiang University
Design and synthesis of biotinylated Hexylselen as a probe to identify KGA allosteric inhibitors by a convenient biomolecular interaction assay.EBI
Zhejiang University
Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance.EBI
Jinan University
Bicyclic-fused heteroaryl or aryl compoundsBDB
Pfizer
Cyclohexyl pyridine derivativeBDB
Kissei Pharmaceutical
A class of 2,4-bisanilinopyrimidine Aurora A inhibitors with unusually high selectivity against Aurora B.BDB
Genentech